» Articles » PMID: 31856756

Occurrence and Determinants of Klebsiella Species Bloodstream Infection in the Western Interior of British Columbia, Canada

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2019 Dec 21
PMID 31856756
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Klebsiella species are among the most common causes of bloodstream infection (BSI). However, few studies have evaluated their epidemiology in non-selected populations. The objective was to define the incidence of, risk factors for, and outcomes from Klebsiella species BSI among residents of the western interior of British Columbia, Canada.

Methods: Population-based surveillance was conducted between April 1, 2010 and March 31, 2017.

Results: 151 episodes were identified for an incidence of 12.1 per 100,000 population per year; the incidences of K. pneumoniae and K. oxytoca were 9.1 and 2.9 per 100,000 per year, respectively. Overall 24 (16%) were hospital-onset, 90 (60%) were healthcare-associated, and 37 (25%) were community-associated. The median patient age was 71.4 (interquartile range, 58.8-80.9) years and 88 (58%) cases were males. Episodes were uncommon among patients aged < 40 years old and no cases were observed among those aged < 10 years. A number of co-morbid medical illnesses were identified as significant risks and included (incidence rate ratio; 95% confidence interval) cerebrovascular accident (5.9; 3.3-9.9), renal disease 4.3; 2.5-7.0), cancer (3.8; 2.6-5.5), congestive heart failure (3.5; 1.6-6.6), dementia (2.9; 1.5-5.2), diabetes mellitus (2.6; 1.7-3.9), and chronic obstructive pulmonary disease (2.3; 1.5-3.5). Of the 141 (93%) patients admitted to hospital, the median hospital length stay was 8 days (interquartile range, 4-17). The in-hospital and 30-day all cause case-fatality rates were 24/141 (17%) and 27/151 (18%), respectively.

Conclusions: Klebsiella species BSI is associated with a significant burden of illness particularly among those with chronic co-morbid illnesses.

Citing Articles

Phenotype and genotype of carbapenem-resistant hypervirulent in a teaching hospital in Shanghai, China.

Ma W, Wan Y, Li X, Huang X, Deng C, Qin Q J Med Microbiol. 2025; 74(3).

PMID: 40042517 PMC: 11897171. DOI: 10.1099/jmm.0.001960.


The burden of hospital acquired infections and antimicrobial resistance.

Abban M, Ayerakwa E, Mosi L, Isawumi A Heliyon. 2023; 9(10):e20561.

PMID: 37818001 PMC: 10560788. DOI: 10.1016/j.heliyon.2023.e20561.


bacteremia mortality: a systematic review and meta-analysis.

Li D, Huang X, Rao H, Yu H, Long S, Li Y Front Cell Infect Microbiol. 2023; 13:1157010.

PMID: 37153146 PMC: 10159367. DOI: 10.3389/fcimb.2023.1157010.


Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study.

MacKinnon M, McEwen S, Pearl D, Lyytikainen O, Jacobsson G, Collignon P BMC Infect Dis. 2021; 21(1):606.

PMID: 34172003 PMC: 8229717. DOI: 10.1186/s12879-021-06326-x.


Klebsiella oxytoca and Emerging Nosocomial Infections.

Neog N, Phukan U, Puzari M, Sharma M, Chetia P Curr Microbiol. 2021; 78(4):1115-1123.

PMID: 33656584 DOI: 10.1007/s00284-021-02402-2.


References
1.
Ellison L, Wilkins K . Canadian trends in cancer prevalence. Health Rep. 2012; 23(1):7-16. View

2.
Zhang Y, Zhao C, Wang Q, Wang X, Chen H, Li H . High Prevalence of Hypervirulent Klebsiella pneumoniae Infection in China: Geographic Distribution, Clinical Characteristics, and Antimicrobial Resistance. Antimicrob Agents Chemother. 2016; 60(10):6115-20. PMC: 5038323. DOI: 10.1128/AAC.01127-16. View

3.
Friedman N, Kaye K, Stout J, McGarry S, Trivette S, Briggs J . Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002; 137(10):791-7. DOI: 10.7326/0003-4819-137-10-200211190-00007. View

4.
Tsay R, Siu L, Fung C, Chang F . Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection. Arch Intern Med. 2002; 162(9):1021-7. DOI: 10.1001/archinte.162.9.1021. View

5.
Rodriguez-Medina N, Barrios-Camacho H, Duran-Bedolla J, Garza-Ramos U . : an emerging pathogen in humans. Emerg Microbes Infect. 2019; 8(1):973-988. PMC: 6609320. DOI: 10.1080/22221751.2019.1634981. View